Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action

Environmental and Molecular Mutagenesis

Volumn 45, Issue 2-3, 2005, Pages 106-114

  Baird, William M ^a   Hooven, Louisa A ^a   Mahadevan, Brinda ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

Carcinogenesis; Complex mixtures; Cytochrome P450; DNA adducts; Polycyclic aromatic hydrocarbon

Indexed keywords

CYTOCHROME P450; DNA; PHORBOL 13 ACETATE 12 MYRISTATE; POLYCYCLIC AROMATIC HYDROCARBON;

CARCINOGENESIS; CELL COMMUNICATION; CELL JUNCTION; DNA ADDUCT; DNA BINDING; GENE MUTATION; METABOLIC ACTIVATION; REVIEW;

BENZO(A)PYRENE; CARCINOGENS, ENVIRONMENTAL; CONNEXINS; CYTOCHROME P-450 ENZYME SYSTEM; DNA; DNA ADDUCTS; MODELS, BIOLOGICAL; MUTATION; POLYCYCLIC HYDROCARBONS, AROMATIC;

EID: 17044423833     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20095     Document Type: Review

References (57)

1. 3H. Cancer Res 33:2378-2385.
2. Baird WM, Dipple A, Grover PL, Sims P, Brookes P. 1973. Studies on the formation of hydrocarbon-deoxyribonucleoside products by the binding of the derivatives of 7-methylbenz(a)anthracene to DNA in aqueous solution and in mouse embryo cells in culture. Cancer Res 33:2386-2392.
3. Baird WM, Harvey RG, Brookes P. 1975. Comparison of the cellular DNA-bound products of benzo(a)pyrene with the products formed by the reaction of benzo(a)pyrene-4, 5 oxide with DNA. Cancer Res 35:54-57.
4. Baird WM, Salmon CP, Diamond L. 1984. Benzo(e)pyrene-induced alterations in the metabolic activation of benzo(a)pyrene and 7, 12-dimethylbenz(a) anthracene by hamster embryo cells. Cancer Res 44:1445-1452.
5. Baird WM, Ralston SL. 1997. Carcinogenic polycyclic aromatic hydrocarbons. In: Sipes IG, McQueen CA, Gandolfi AJ, editors. Comprehensive toxicology, vol. 12. Cambridge: Cambridge University Press. p 171-200.
6. Bláha L, Kapplová P, Vondráček J, Upham B, Machala M. 2002. Inhibition of gap-junctional intercellular communication by environmentally occurring polycyclic aromatic hydrocarbons. Toxicol Sci 65:43-51.
7. Boffetta P, Jourenkova N, Gustavsson P. 1997. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control 8:444-472.
8. Borgen A, Darvey H, Castagnoli N, Crocker TT, Rasmussen RE, Wang IY. 1973. Metabolic conversion of benzo[a]pyrene by Syrian hamster liver microsomes and binding of metabolite to deoxyribonucleic acid. J Med Chem 16:502-506.
9. Boyland E. 1950. The biological significance of metabolism of polycyclic compounds. Biochem Soc Symp 5:40-54.
10. Brookes P, Lawley PD. 1964. Evidence for the binding of polynuclear aromatic hydrocarbons to the nucleic acids of mouse skin: relation between carcinogenic power of hydrocarbons and their binding to deoxyribonucleic acid. Nature 202:781-784.
11. Buters J, Mahadevan B, Quintanilla-Martinez L, Gonzalez FJ, Greim H, Baird WM, Luch A. 2002. Cytohrome P450 1B1 determines susceptibility to dibenzo[a, l]pyrene-induced tumor formation. Chem Res Toxicol 15:1127-1135.
12. Chen I, Hsieh T, Thomas T, Safe S. 2001. Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization. Gene 262:207-214.
13. Conney AH. 1982. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 42:4875-4917.
14. Cook JW, Hewett CL, Hieger I. 1933. The isolation of a cancer-producing hydrocarbon from coal tar. J Chem Soc 395:1-3.
15. Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA. 1998. A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis 19:117-124.
16. Deutsch-Wenzel R, Brune H, Grimmer G, Dettbarn G, Misfeld J, Timm J. 1984. Investigation on the carcinogenicity of emission condensate from brown coal fired residential stoves chronical applied to mouse skin. Cancer Lett 25:103-111.
17. Dipple A, Khan QA, Page JE, Ponten I, Szeliga J. 1999. DNA reactions, mutagenic action and stealth properties of polycyclic aromatic hydrocarbon carcinogens. Int J Oncol 14:103-111.
18. Gonzalez FJ. 2001. The use of gene knockout mice to unravel the mechanisms of toxicity and chemical carcinogenesis. Toxicol Lett 120:199-208.
19. Gradin K, McGuire J, Wenger RH, Kvietikova I, Whitelaw ML, Toftgard R, Tora L, Gassmann M, Poellinger L. 1996. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol 16:5221-5231.
20. Grimmer G, Brune H, Deutsch-Wenzel R, Dettbarn G, Misfeld J. 1987. Contribution of polycyclic aromatic hydrocarbons and polar polycyclic aromatic compounds to the carcinogenic impact of flue gas condensate from coal-fired residential furnaces evaluated by implantation into the rat lung. J Natl Cancer Inst 78:935-941.
21. Hengstler JG, Van der Burg B, Steinberg P, Oesch F. 1999. Interspecies differences in cancer susceptibility and toxicity. Drug Metab Rev 31:917-970.
22. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. 1999. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870-4875.
23. Inouye K, Mizokawa T, Saito A, Tonomura B, Ohkawa H. 2000. Biphasic kinetic behavior of rat cytochrome P-4501A1-dependent monooxygenation in recombinant yeast microsomes. Biochim Biophys Acta 1481:265-272.
24. Lehr RE, Jerina DM. 1977. Relationships of quantum mechanical calculations, relative mutagenicity of benzo[a]anthracene diol epoxides, and "bay region" concept of aromatic hydrocarbon carcinogenicity. J Toxiocol Environ Health 2:1259-1265.
25. Levin W, Wood AW, Chang RL, Slaga TJ, Yagi H, Jerina DM, Conney AH. 1977a. Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7, 8,-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin. Cancer Res 37:2721-2725.
26. Levin W, Wood AW, Wislocki PG, Kapitulnik J, Yagi H, Jerina DM, Conney AH. 1977b. Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin. Cancer Res 37:3356-3361.
27. Levin W, Wood AW, Wislocki PG, Chang RL, Kapitulnik J, Mah HD, Yagi H, Jerinab DM, Conney AH. 1978. Mutagenicity and carcinogenicity of benzo(a)pyrene and benzo(a)pyrene derivatives. In: Gelboin HV, Ts'o POP, editors. Polycyclic hydrocarbons and cancer, vol. 1. New York: Academic Press. p 189-202.
28. Mahadevan B, Luch A, Seidel A, Pelling JC, Baird WM. 2001. Effects of the (-)-anti-11R, 12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene on DNA adduct formation and cell cycle arrest in human diploid fibroblasts. Carcinogenesis 22:161-169.
29. Mahadevan B, Dashwood WM, Luch A, Pecaj A, Doehmer J, Seidel A, Pereira C, Baird WM. 2003. Mutations induced by (-)-anti-11R, 12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells. Environ Mol Mutagen 41:131-139.
30. Mangelsdorf I, Boehncke A, Holländer W. 1998. Auswertung einer dermalen Kanzerogenitätsstudie an Mäusen mit zwei vershiedenen teerölprodukten. Hanover: Fraunhofer-Institut für Toxikologie und Aerosolforschung.
31. Marston CP, Pereira C, Ferguson J, Fischer K, Hedstrom O, Dashwood WM, Baird WM. 2001. Effect of a complex environmental mixture from coal tar containing polycyclic aromatic hydrocarbons (PAH) on the tumor initiation, PAH-DNA binding and metabolic activation of carcinogenic PAH in mouse epidermis. Carcinogenesis 22:1077-1086.
32. Mastrangelo G, Fadda E, Marzia V. 1996. Polycyclic aromatic hydrocarbons and cancer in man. Environ Health Perspect 104:1166-1170.
33. Miller KP, Ramos KS. 2001. Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons. Drug Metab Rev 33:1-35.
34. Milo GE, Shuler CF, Lee H, Casto BC. 1995. A conundrum in molecular toxicology: molecular and biological changes during neoplastic transformation of human cells. Cell Biol Toxicol 11:329-345.
35. Moriguchi T, Motohashi H, Hosoya T, Nakajima O, Takahashi S, Ohsako S, Aoki Y, Nishimura N, Tohyama C, Fujii-Kuriyama Y, Yamamoto M. 2003. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci USA 100:5652-5657.
36. National Institute of Standards and Technology. 1992. Certificate of analysis: standard reference material 1597 - complex mixture of polycyclic aromatic hydrocarbons from coal tar. Washington, DC: National Institute of Standards and Technology.
37. National Research Council. 1983. Polycyclic aromatic hydrocarbons: evaluation of sources and effects. Washington, DC: National Academy Press.
38. Phillips DH. 1999. Polycyclic aromatic hydrocarbons in the diet. Mutat Res 443:139-147.
39. Pott P. 1963. Chirurgical observations. Natl Cancer Inst Monogr 10:7.
40. Pullman A, Pullman B. 1955. Electronic structure and carcinogenic activity of aromatic molecules: new developments. Adv Cancer Res 3:117-169.
41. Reiners JJ Jr, Nesnow S, Slaga TJ. 1984. Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion. Carcinogenesis 5:301-307.
42. Rubin H. 2001. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 22:1903-1930.
43. Salama SA, Sierra-Torres CH, Oh HY, Hamada FA, Au WW. 2001. Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ Mol Mutagen 37:17-26.
44. Schneider K, Roller M, Kalberlah F, Schuhmacher-Wolz U. 2002. Cancer risk assessment for oral exposure to PAH mixtures. J Appl Toxicol 22:73-83.
45. Schwarz D, Kisselev P, Honeck H, Cascorbi I, Schunck WH, Roots I. 2001. Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system. Xenobiotica 31:345-356.
46. Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP. 1998. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. Chem Res Toxicol 11:1048-1056.
47. Shimada T, Oda Y, Gillam EM, Guengerich FP, Inouye K. 2001. Metabolic activation of polycyclic aromatic hydrocarbons and other procarcinogens by cytochromes P450 1A1 and P450 1B1 allelic variants and other human cytochromes P450 in Salmonella typhimurium NM2009. Drug Metab Dispos 29:1176-1182.
48. Shimada T, Fujii-Kuriyama Y. 2004. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochrome P450 1A1 and 1B1. Cancer Sci 95:1-6.
49. Sims P, Grover PL, Swaisland A, Pal K, Hewer A. 1974. Metabolic activation of benzo[a]pyrene proceeds by diol-epoxide. Nature 252: 326-327.
50. Townsend AJ, Kiningham KK, St Clair D, Tephly TR, Morrow CS, Guengerich FP. 1999. Symposium overview: characterization of xenobiotic metabolizing enzyme function using heterologous expression systems. Toxicol Sci 48:143-150.
51. Van Duuren BL, Goldschmidt BM. 1976. Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. J Natl Cancer Inst 56:1237-1242.
52. 1-S-phase transition by polycyclic aromatic hydrocarbons in human breast carcinoma MCF-7 cells. Toxicol Sci 70:193-201.
53. Weyand EH, Chen YC, Wu Y, Koganti A, Dunsford HA, Rodriguez LV. 1995. Differences in the tumorigenic activity of a pure hydrocarbon and a complex mixture following ingestion: benzo(alpha)pyrene vs manufactured gas plant residue. Chem Res Toxicol 8:949-954.
54. White PA. 2002. The genotoxicity of priority polycyclic aromatic hydrocarbons in complex mixtures. Mutat Res 515:85-98.
55. Whitlock JP Jr. 1999. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39:103-125.
56. Wu M, Yan S, Patel DJ, Geacintov NE, Broyde S. 2002. Relating repair susceptibility of carcinogen-damaged DNA with structural distortion and thermodynamic stability. Nucl Acids Res 30:3422-3432.
57. Zeiger E. 2003. Illusions of safety: antimutagens can be mutagens, and anti-carcinogens can be carcinogens. Mutat Res 543:191-194.